Urologic Oncology Program

Adobedoctor holding graphic virtual visualization model of Bladder organThe experts who make up the Urologic Oncology Program at Rutgers Cancer Institute are keenly focused on providing care that meets the unique needs of each individual. We provide highly specialized and compassionate care for patients with tumors of genitourinary tract. To request an appointment, call 844-CANCERNJ

Our team offers an unparalleled level of expertise and comprehensive services committed to improving patient outcomes in a comfortable and enriching environment. Our physicians specialize in the diagnosis and treatment of tumors of the prostate, testis, kidney, and bladder.  

Rutgers Cancer Institute is a leader in laparoscopic renal procedures and robotic surgery and has extensive experience performing robotic prostatectomies – our urologic oncologists have performed more than 1,500 robotic radical prostatectomies and more than 600 partial and/or radical nephrectomies in the past 5 years. Nearly 150 radical cystectomies are performed annually at our center.

Our Prostate Cancer Program provides a hub for basic and clinical research in prostate cancer as well as a forum for prostate cancer outreach. 

The Latest Diagnostic and Treatment Options

Rutgers Cancer Institute and Robert Wood Johnson University Hospital provides access to the latest technological advancements for prostate and bladder cancer, including the most comprehensive clinical trial portfolio for genitourinary cancers in the state of New Jersey.

Blue Light Cystoscopy

The Urologic Oncology Program at Rutgers Cancer Institute and Robert Wood Johnson University Hospital offers blue light cystoscopy with Cysview® to help improve detection of certain bladder cancers. Cysview is an optical imaging agent that makes non-muscle invasive bladder cancer glow bright pink in blue light, enabling urologists to better see and remove tumors with greater accuracy.

Jelmyto Treatment for Upper Urinary Tract Urothelial Cancer

Jelmyto is a brand of mitomycin gel, which is a reverse thermal hydrogel that has the chemotherapeutic drug, mitomcyin in it. It has been a standard in the management of non-muscle invasive urothelial carcinoma of the bladder for some time, and recently was innovated to effectively treat the kidneys and other upper tract disease.

Additional Treatments

  • MRI with Ultrasound Fusion Prostate Biopsy 
  • Single-Port and Multi-Port Robotic Surgery


USNWR Prostate CancerRutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, earned several High Performing ratings in the 2023-2024 U.S. News & World Report Best Hospitals survey, including for prostate cancer surgery. In fact, University Hospital was 1 of 4 New Jersey hospitals afforded this designation.

Rutgers Cancer Institute was also designated a Testicular Cancer Center of Excellence by the Testicular Cancer Awareness Foundation and the Testicular Cancer Resource Center, which are two leading testicular cancer organizations in the U.S.

To request an appointment, call 844-CANCERNJ. | Find Urologic Oncology Clinical Trials.

Your Urologic Oncology Team

Related Articles and Press